M3V — MeVis Medical Solutions AG Share Price
0.000.00%
Last trade - 00:00- €42.95m
- €35.21m
- €17.34m
- 96
- 67
- 37
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.41 | ||
| Price to Tang. Book | 2.41 | ||
| Price to Free Cashflow | 7.44 | ||
| Price to Sales | 2.48 | ||
| EV to EBITDA | 7.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.37% | ||
| Return on Equity | 27.6% | ||
| Operating Margin | 22.46% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 18.07 | 17.13 | 16.21 | 18.76 | 17.34 | n/a | n/a | -0.49% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5.93 | -29.33 | -20.31 | +71.35 | -36.84 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mevis Medical Solutions AG is a Germany-based provider of software and services for the medical image processing industry, and offers computer support for image-based medical diagnosis and therapy. The Company develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The Company's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.
Directors
- Last Annual
- September 30th, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- September 6th, 2006
- Public Since
- November 16th, 2007
- No. of Employees
- 101
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 1,820,000
- Address
- Caroline-Herschel-Str. 1, BREMEN, 28359
- Web
- https://www.mevis.de/
- Phone
- +49 421224950
- Auditors
- Deloitte GmbH
Upcoming Events for M3V
Similar to M3V
Aap Implantate AG
XETRA
Bio-Gate AG
XETRA
FAQ
What is the MeVis Medical Solutions AG share price?
As of Today at 19:14 UTC, shares in MeVis Medical Solutions AG are trading at €23.60. This share price information is delayed by 15 minutes.
How has the MeVis Medical Solutions AG share price performed this year?
Shares in MeVis Medical Solutions AG last closed at €23.60 and the price had moved by -28.92% over the past 365 days. In terms of relative price strength the MeVis Medical Solutions AG share price has underperformed the FTSE Global All Cap Index by -34.43% over the past year.
What are the analyst and broker recommendations for MeVis Medical Solutions AG?
The overall consensus recommendation for MeVis Medical Solutions AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the MeVis Medical Solutions AG dividend yield?
The MeVis Medical Solutions AG dividend yield is 4.03% based on the trailing twelve month period.
Does MeVis Medical Solutions AG pay a dividend?
Last year, MeVis Medical Solutions AG paid a total dividend of €0.95, and it currently has a trailing dividend yield of 4.03%. We do not have any data on when MeVis Medical Solutions AG is to next pay dividends.
When does MeVis Medical Solutions AG next pay dividends?
We do not have data on when MeVis Medical Solutions AG is to next pay dividends. The historic dividend yield on MeVis Medical Solutions AG shares is currently 4.03%.
How do I buy MeVis Medical Solutions AG shares?
To buy shares in MeVis Medical Solutions AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MeVis Medical Solutions AG?
As of the previous close price of €23.60, shares in MeVis Medical Solutions AG had a market capitalisation of €42.95m.
Where are MeVis Medical Solutions AG shares listed?
Here are the trading details for MeVis Medical Solutions AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: M3V
What kind of share is MeVis Medical Solutions AG?
Based on an overall assessment of its quality, value and momentum MeVis Medical Solutions AG is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MeVis Medical Solutions AG share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the MeVis Medical Solutions AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MeVis Medical Solutions AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -22.49%.
As of the last closing price of €23.60, shares in MeVis Medical Solutions AG were trading -12.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MeVis Medical Solutions AG PE Ratio?
The MeVis Medical Solutions AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €23.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MeVis Medical Solutions AG?
MeVis Medical Solutions AG's management team is headed by:
- Kimberley Honeysett - CSU
- Marcus Kirchhoff - CMG
- Sunny Sanyal - VCH
- Matthew Lowell - SUB